Published on
November 6, 2025
- 17:26 GMT
NeuroCytonix Authorized by COFEPRIS to Launch Neuro-Restorative Treatment Program in Mexico
ROCKVILLE, MD, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- NeuroCytonix Inc., a U.S.-based biomedical technology company dedicated to advancing brain repair and regeneration, announced today that its subsidiary, NeuroCytonix México S.A. de C.V …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
